eHealth (EHTH)
(Delayed Data from NSDQ)
$4.86 USD
-0.17 (-3.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.86 USD
-0.17 (-3.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Zacks News
eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).
eHealth (EHTH) Targets 8-10% Adjusted EBITDA Margin by 2025
by Zacks Equity Research
By the trailing 12-month period ending March 2025, eHealth (EHTH) expects to enter the positive operating cash flow region.
EHealth (EHTH) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -21.52% and 20.35%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 13.04% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 1.07% and 2.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Brown & Brown (BRO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 3.70% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Marsh & McLennan (MMC) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 3.27% and 1.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Arthur J. Gallagher (AJG) Closes Buck Buyout, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher (AJG) bought partnership interest in BCHR Holdings, L.P., dba Buck and its subsidiaries for $660 million to consolidate its portfolio of professional services.
Brown & Brown (BRO) Boosts Canada Presence With HBG Buyout
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Highcourt Partners is likely to provide it solid opportunities and a robust leadership team to boost growth in Canada.
Is Euronet Worldwide (EEFT) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Euronet Worldwide (EEFT) and eHealth (EHTH) have performed compared to their sector so far this year.
eHealth (EHTH) Q4 Earnings Top, Approved Members Fall Y/Y
by Zacks Equity Research
eHealth (EHTH) Q4 results reflect lower operating costs and expenses. However, revenues declined and so did approved members.
EHealth (EHTH) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 147.83% and 12.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
EHealth (EHTH) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 17.61% and 9.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Tops Q3 Earnings Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of 0.50% and 3.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 2.80% and 1.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Brown & Brown (BRO) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of -16.67% and 1.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
EHealth (EHTH) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -26.37% and 34.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CareTrust REIT (CTRE) Q2 FFO Beat Estimates
by Zacks Equity Research
CareTrust REIT (CTRE) delivered FFO and revenue surprises of 5.71% and 0.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of 2.33% and 0.86%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Q2 Earnings Top Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 0.43% and 2.28%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Hold eHealth (EHTH) Stock for Now
by Zacks Equity Research
eHealth (EHTH) continues to benefit from growth in Medicare Advantage plan members, higher commission revenues and higher internal agent productivity.
EHealth (EHTH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 14.95% and 1.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of -0.62% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: eHealth (EHTH) Q1 Earnings Expected to Decline
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EHealth (EHTH) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -53.33% and 2.39%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?